“Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
, “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
, “Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.”, Ophthalmology, vol. 120, no. 1, pp. 140-50, 2013.
, “Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD.”, Invest Ophthalmol Vis Sci, vol. 53, no. 8, pp. 4626-33, 2012.
, “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
, “Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.”, Invest Ophthalmol Vis Sci, vol. 49, no. 9, pp. 3864-9, 2008.
, “Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.”, Ophthalmology, vol. 123, no. 12, pp. 2554-2570, 2016.
, “Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.”, Ophthalmology, vol. 117, no. 3, pp. 489-99, 2010.
, “Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.”, Ophthalmology, vol. 119, no. 12, pp. 2622-30, 2012.
, “Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 56, no. 1, pp. 330-8, 2014.
, “Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.”, Ophthalmology, vol. 115, no. 11, pp. 1957-64, 2008.
, “Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.”, Ophthalmology, vol. 122, no. 10, pp. 2053-62, 2015.
, “Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.”, Ophthalmology, vol. 122, no. 5, pp. 888-96, 2015.
,